硝苯地平联合拉贝洛尔治疗妊娠期高血压患者的临床疗效分析

Analysis of Clinical Efficacy of Nifedipine Combined with Labetalol in Treatment of Patients with Pregnancy Induced Hypertension

目的分析妊娠期高血压患者行硝苯地平、拉贝洛尔联合疗法的效果。方法从该院2014年1月—2015年12月收治的妊娠期高血压患者中方便抽选实施硝苯地平疗法的100例作为对照组,实施硝苯地平、拉贝洛尔疗法的100例作为实验组,评定疾病治疗后的血压指标、妊娠解决和并发症。结果实验组预后收缩压(120.62±8.01)mm Hg,舒张压(77.04±4.46)mm Hg;对照组预后收缩压(145.20±10.69)mm Hg,舒张压(89.67±6.08)mm Hg,两组差异有统计学意义,P<0.05;实验组的妊娠结局、并发症率低于对照组,差异有统计学意义,P<0.05。结论临床给予妊娠期高血压患者硝苯地平、拉贝洛尔联合疗法作用突出,可改善血压,预防不良妊娠结局,值得借鉴。

Objective To analyze gestational hypertension patients with nifedipine, labetalol the effect of combination therapy. Methods Convenient selection from our hospital in January 2014 and December 2015 in patients with pregnancy induce.d hypertension and decimating the implementation of nifedipine therapy of 100 cases as control group, the implementation of nifedipine and labetalol in treatment of 100 cases as the experimental group, the indexes of the blood pressure after treatment of disease assessment, pregnancy and complications. Results The prognosis of systolic blood pressure（120.62 ±8.01） mm Hg, diastolic blood pressure（77.04 ± 4.46） mm Hg; Prognosis of systolic blood pressure（145.20 ± 10.69） controls mm Hg, diastolic blood pressure（89.67 ± 6.08） mm Hg, with a statistical difference,P〈0.05; Experimental pregnancy outcome and complication rate is lower than the control group, statistical differences, P〈0.05. Conclusion Clinical pregnancy hypertension patients＇ nifedipine, labetalol combination therapy effect is outstanding, can improve blood pressure, prevent adverse pregnancy outcomes, is worth using for reference.